{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:49:47Z","timestamp":1794584987012,"version":"4.9.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T00:00:00Z","timestamp":1538006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Yu Professorship in Nephrology"},{"DOI":"10.13039\/501100003803","name":"University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1093\/ndt\/gfy262","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T13:58:44Z","timestamp":1532095124000},"page":"914-920","source":"Crossref","is-referenced-by-count":67,"title":["An update on cancer after kidney transplantation"],"prefix":"10.1093","volume":"34","author":[{"given":"Chi Yuen","family":"Cheung","sequence":"first","affiliation":[{"name":"Renal Unit, Department of Medicine, Queen Elizabeth Hospital, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney Chi Wai","family":"Tang","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,9,27]]},"reference":[{"key":"2019060303551774400_gfy262-B1","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1681\/ASN.2008090998","article-title":"Association of CKD and cancer risk in older people","volume":"20","author":"Wong","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2019060303551774400_gfy262-B2","doi-asserted-by":"crossref","first-page":"e8077","DOI":"10.1097\/MD.0000000000008077","article-title":"Cancer risk in patients with diabetic nephropathy: a retrospective cohort study","volume":"96","author":"Cheung","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2019060303551774400_gfy262-B3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: an international collaborative study","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet"},{"key":"2019060303551774400_gfy262-B4","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"key":"2019060303551774400_gfy262-B5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000445362","article-title":"Cancer incidence and mortality in Chinese dialysis population: a multicenter cohort study","volume":"43","author":"Cheung","year":"2016","journal-title":"Am J Nephrol"},{"key":"2019060303551774400_gfy262-B6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1525-139X.2010.00804.x","article-title":"Cancer screening in people who have chronic disease: the example of kidney disease","volume":"24","author":"Wong","year":"2011","journal-title":"Semin Dial"},{"key":"2019060303551774400_gfy262-B7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ki.1991.192","article-title":"Acquired cystic kidney disease","volume":"40","author":"Grantham","year":"1991","journal-title":"Kidney Int"},{"key":"2019060303551774400_gfy262-B8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ki.1995.286","article-title":"Screening for acquired cystic kidney disease: a decision analytic perspective","volume":"48","author":"Sarasin","year":"1995","journal-title":"Kidney Int"},{"key":"2019060303551774400_gfy262-B9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/ajt.13978","article-title":"Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines","volume":"17","author":"Acuna","year":"2017","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6601219","article-title":"Cancer risk following organ transplantation: a nationwide cohort study in Sweden","volume":"89","author":"Adami","year":"2003","journal-title":"Br J Cancer"},{"key":"2019060303551774400_gfy262-B11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1600-6143.2004.00450.x","article-title":"Cancer after kidney transplantation in the United States","volume":"4","author":"Kasiske","year":"2004","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B12","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1600-6143.2007.01736.x","article-title":"Cancer incidence among Canadian kidney transplant recipients","volume":"7","author":"Villeneuve","year":"2007","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B13","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/j.1600-6143.2010.03181.x","article-title":"Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit","volume":"10","author":"Collett","year":"2010","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B14","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1111\/ajt.13862","article-title":"Risk of renal cell carcinoma among kidney transplant recipients in the United States","volume":"16","author":"Karami","year":"2016","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/BF02574501","article-title":"Malignancy after renal transplantation: incidence and role of type of immunosuppression","volume":"9","author":"Tremblay","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"2019060303551774400_gfy262-B17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(97)08496-1","article-title":"Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens","volume":"351","author":"Dantal","year":"1998","journal-title":"Lancet"},{"key":"2019060303551774400_gfy262-B18","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1681\/ASN.2009101043","article-title":"Long-term cancer risk of immunosuppressive regimens after kidney transplantation","volume":"21","author":"Gallagher","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2019060303551774400_gfy262-B19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0041-1345(96)00151-0","article-title":"Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation","volume":"29","author":"Sheil","year":"1997","journal-title":"Transpl Proc"},{"key":"2019060303551774400_gfy262-B20","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation","volume":"63","author":"Pirsch","year":"1997","journal-title":"Transplantation"},{"key":"2019060303551774400_gfy262-B21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00007890-199808270-00014","article-title":"A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the US FK506 Study Group","volume":"66","author":"Wiesner","year":"1998","journal-title":"Transplantation"},{"key":"2019060303551774400_gfy262-B22","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1111\/j.1600-6143.2005.01125.x","article-title":"Prospective Registry-Based Observational Cohort Study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil","volume":"5","author":"Robson","year":"2005","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B23","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2012.04004.x","article-title":"Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer","volume":"12","author":"Campbell","year":"2012","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1681\/ASN.2005090993","article-title":"Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation","volume":"17","author":"Campistol","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2019060303551774400_gfy262-B25","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"key":"2019060303551774400_gfy262-B26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-6143.2012.04281.x","article-title":"Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation","volume":"13","author":"Isakova","year":"2013","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/ajt.12969","article-title":"Sirolimus use and cancer incidence among US kidney transplant recipients","volume":"15","author":"Yanik","year":"2015","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B28","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/ndt\/gfw088","article-title":"Immunosuppression with mammalian target of rapamycin inhibitor and incidence of post-transplant cancer in kidney transplant recipients","volume":"31","author":"Opelz","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2019060303551774400_gfy262-B29","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1600-6143.2011.03914.x","article-title":"Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys","volume":"12","author":"Pestana","year":"2012","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/ajt.13550","article-title":"BK polyomavirus infection and renourinary tumorigenesis","volume":"16","author":"Papadimitriou","year":"2016","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/ajt.14530","article-title":"Treatment for presumed BK polyomavirus nephropathy and risk of urinary tract cancers among kidney transplant recipients in the United States","volume":"18","author":"Gupta","year":"2018","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B32","doi-asserted-by":"crossref","first-page":"S394","DOI":"10.1111\/j.1432-2277.2000.tb02068.x","article-title":"Cancer incidence in a kidney-transplanted population","volume":"13","author":"Kyll\u00f6nen","year":"2000","journal-title":"Transpl Int"},{"key":"2019060303551774400_gfy262-B33","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among U.S. solid organ transplant recipients: the Transplant Cancer Match Study","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"2019060303551774400_gfy262-B34","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1111\/j.1600-6143.2012.04209.x","article-title":"Malignancy after kidney transplantation: Hong Kong Renal Registry","volume":"12","author":"Cheung","year":"2012","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B35","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1600-6143.2009.02728.x","article-title":"Cancer mortality in kidney transplantation","volume":"9","author":"Kiberd","year":"2009","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B36","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1097\/TP.0000000000000760","article-title":"Cancer-specific and all-cause mortality in kidney transplant recipients with and without previous cancer","volume":"99","author":"Viecelli","year":"2015","journal-title":"Transplantation"},{"key":"2019060303551774400_gfy262-B37","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.transproceed.2007.08.078","article-title":"Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies","volume":"39","author":"Boraty\u0144ska","year":"2007","journal-title":"Transplant Proc"},{"key":"2019060303551774400_gfy262-B38","doi-asserted-by":"crossref","first-page":"44833","DOI":"10.18632\/oncotarget.14908","article-title":"Conversion to mammalian target of rapamycin inhibitors in kidney transplant recipients with de novo cancers","volume":"8","author":"Cheung","year":"2017","journal-title":"Oncotarget"},{"key":"2019060303551774400_gfy262-B39","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi's sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"key":"2019060303551774400_gfy262-B40","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/tri.12375","article-title":"CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality","volume":"27","author":"Rabot","year":"2014","journal-title":"Transpl Int"},{"key":"2019060303551774400_gfy262-B41","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ki.2013.253","article-title":"Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival","volume":"85","author":"Serre","year":"2014","journal-title":"Kidney Int"},{"key":"2019060303551774400_gfy262-B42","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/ajt.13711","article-title":"Checkpoint inhibitors in kidney transplant recipients and the potential risk of rejection","volume":"16","author":"Alhamad","year":"2016","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1056\/NEJMc1614298","article-title":"Preserved renal-allograft function and the PD-1 pathway inhibitor nivolumab","volume":"376","author":"Barnett","year":"2017","journal-title":"N Engl J Med"},{"key":"2019060303551774400_gfy262-B44","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/AOG.0b013e318277c92a","article-title":"ACOG Practice Bulletin Number 131: screening for cervical cancer","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"2019060303551774400_gfy262-B45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-6143.2001.000100.x","article-title":"The evaluation of renal transplantation candidates: clinical practice guidelines","volume":"1","author":"Kasiske","year":"2001","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B46","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1681\/ASN.V11suppl_1s1","article-title":"Recommendations for the outpatient surveillance of renal transplant recipients","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"2019060303551774400_gfy262-B47","first-page":"3","article-title":"Section IV: long-term management of the transplant recipient. IV. 6.3. Cancer Risk after Renal Transplantation. Solid Organ Cancers: Prevention and Treatment","volume":"17","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"2019060303551774400_gfy262-B48","doi-asserted-by":"crossref","first-page":"e4657","DOI":"10.1136\/bmj.e4657","article-title":"Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy","volume":"345","author":"Collins","year":"2012","journal-title":"BMJ"},{"key":"2019060303551774400_gfy262-B49","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guidelines for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"2019060303551774400_gfy262-B50","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/34\/6\/914\/28750732\/gfy262.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T23:53:50Z","timestamp":1661644430000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/34\/6\/914\/5107809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,27]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,9,27]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfy262","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2018,9,27]]}}}